Rheumatology Advisor
WEBThe Grand Roundup: Pediatric Rheumatology. The Grand Roundup: Rheumatoid Arthritis. The Grand Roundup: Systemic Lupus Erythematosus. Rheumatology Advisor Update. Rheumtaology Advisor offers featured …
American College of Rheumatology Releases Updated …
WEBJun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published …
2022 ACR/AAHKS Guidelines for Management of
WEBApr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons …
Ehlers-Danlos Syndrome - Rheumatology Advisor
- Ehlers-Danlos syndrome is a group of inherited connective tissue disorders that primarily affects the skin, joints, and blood vessel walls1 but can affect every organ system and result in significant morbidity and mortality.2 Typical clinical manifestations are skin hyperelasticity, hypermobility of joints, the fragility of blood vessels,2and atrop...
Osteoarthritis - Rheumatology Advisor
WEBAug 10, 2022 · Osteoarthritis affects weight-bearing joints especially the knee and hip; it rarely starts with smaller joints. Osteoarthritis is the leading form of arthritis, contributing to significant joint pain and disability, and …
2022 ACR Guideline Update for the Prevention and Treatment of ...
WEBDec 8, 2023 · The updated guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis covered the period from April 23, 2016, to January 24, 2022. The …
Upadacitinib Is Safe and Effective for Treating Rheumatoid Arthritis ...
WEBMay 31, 2024 · Upadacitinib is safe and effective for treating rheumatoid arthritis (RA) over 5 years, according to study results published in The Journal of Rheumatology.. The …
What Rheumatologists Need to Know About Cancer …
WEBApr 30, 2021 · In the United States, the lifetime risk of developing cancer is 1 in 3 individuals. 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and …
Overview of Latest Treatment Strategies for Active …
WEBAn abstract presented at ACR 2023 reported on the results of the interleukin (IL)-17 inhibitor bimekizumab among patients with active PsA from the BE OPTIMAL (ClinicalTrials.gov identifier: NCT03895203) and …
Choosing the Right TNF Inhibitor Therapy for Rheumatoid Arthritis
WEBDecember 20, 2017. Biologics, approved nearly 20 years ago for the treatment of rheumatoid arthritis (RA), transformed treatment, and tumor necrosis factor inhibitors …